ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 124 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $436,642 | +4.0% | 187,400 | -14.8% | 0.53% | +16.4% |
| Q3 2022 | $420,000 | -29.5% | 220,000 | 0.0% | 0.46% | -24.3% |
| Q2 2022 | $596,000 | 0.0% | 220,000 | +10.0% | 0.60% | +65.8% |
| Q1 2022 | $596,000 | -43.2% | 200,000 | -25.9% | 0.36% | -22.6% |
| Q4 2021 | $1,050,000 | -28.0% | 270,000 | -20.6% | 0.47% | -11.5% |
| Q3 2021 | $1,459,000 | +41.7% | 340,000 | 0.0% | 0.53% | +55.9% |
| Q2 2021 | $1,030,000 | +18.9% | 340,000 | +30.8% | 0.34% | +1.5% |
| Q1 2021 | $866,000 | – | 260,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |